Depression, AnxietyNCT06484400
Cognitive Behavioral Therapy Versus Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms
A study testing Cognitive Behavioral Therapy and Ericksonian Hypnotehrapy in people with Depression, Anxiety, run by Istanbul Nisantasi University at 1 site in Turkey (Türkiye).
Trial summary
Title: Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; A Controlled Randomized Study. Principal Investigator: Dr. Metin Çınaroğlu, Istanbul Nişantaşı University, Department of Psychology. Study Duration: October, 2023 - Ongoing. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Depression, Anxiety
- What is being tested?
- Cognitive Behavioral Therapy and Ericksonian Hypnotehrapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 45 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 4 Sep 2024to 1 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age: Participants must be between 18 and 65 years old.
- Symptoms: Participants must display symptoms of depression and/or anxiety, but not necessarily have a clinical diagnosis.
- Voluntary Participation: Participants must voluntarily agree to participate and must be able to provide informed consent.
- Residency: Participants must reside in or near the study location (Istanbul) to attend in-person sessions.
- Language: Participants must be proficient in the language in which the therapy is delivered (presumably Turkish).
- Availability: Participants must be available to attend all scheduled sessions over the course of the study (12 weekly sessions).
Who cannot join
- Psychiatric Diagnosis: Individuals with a severe psychiatric disorder requiring immediate or intensive intervention (e.g., schizophrenia, bipolar disorder, or severe depression with suicidal ideation).
- Current Psychotherapy: Individuals currently receiving other forms of psychotherapy or psychological treatment.
- Substance Abuse: Individuals with active substance abuse issues or dependencies that could interfere with therapy.
- Cognitive Impairments: Individuals with cognitive impairments or neurological disorders that would limit their ability to participate fully in therapy.
- Medical Conditions: Individuals with severe medical conditions that could interfere with participation in the study or pose a risk during the therapy sessions.
- Language Barrier: Non-Turkish speakers or those who do not understand the language well enough to benefit from therapy conducted in Turkish.
- Previous Participation: Individuals who have previously participated in similar studies or interventions, to avoid potential biases in responses and outcomes.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; Controlled Randomized Study
Title: Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; A Controlled Randomized Study.
Principal Investigator: Dr. Metin Çınaroğlu, Istanbul Nişantaşı University, Department of Psychology.
Read more
Study Duration: October, 2023 - Ongoing.
Objective: The study aims to compare the effectiveness of Cognitive Behavioral Therapy (CBT) and Ericksonian Hypnotherapy in alleviating symptoms of depression and anxiety among volunteers in Istanbul.
Methods: This randomized controlled trial will enroll healthy individuals aged 18-65 who exhibit symptoms of depression and anxiety but are not clinically diagnosed. Participants will be randomly divided into three groups: one receiving CBT, another receiving Ericksonian Hypnotherapy, and a control group receiving no therapeutic intervention. Standard psychological assessment tools such as the Beck Depression Inventory and Beck Anxiety Inventory will be used to measure outcomes.
Significance: Depression and anxiety are prevalent psychological disorders that significantly impair quality of life. Comparing these two therapeutic approaches may provide valuable insights into more effective psychological treatment strategies, thereby enhancing patient care in mental health settings.
Study Protocol:
Recruitment: 150 volunteers will be screened using socio-demographic forms and psychological assessments.
Intervention: Participants will undergo CBT or Ericksonian Hypnotherapy according to their group allocation, while the control group will be observed without intervention.
Evaluation: Pre- and post-treatment assessments will gauge the therapy's impact on depression and anxiety symptoms.
Expected Outcome: The study expects to demonstrate the relative efficacy of CBT and Ericksonian Hypnotherapy, providing evidence to guide treatment choices for managing depression and anxiety symptoms.
Read the detailed description
Study Title: Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; A Controlled Randomized Study.
Principal Investigator: Dr. Metin Çınaroğlu, Associate Professor, Department of Psychology, Istanbul Nişantaşı University.
Co-Investigators:
Expert Psychologist Dr. Eda Yılmazer, Department of Psychology, Beykoz University.
Psychologist Cemre Odabaşı, Clinical Psychology (Thesis) Student, Istanbul Nişantaşı University.
Dr. Selami Varol Ülker, Department of Psychology, Üsküdar University. Prof. Dr. Gökben Hızlı Sayar, Psychiatrist, Department of Psychiatry, Üsküdar University.
Study Duration: Start Date: October, 2023 - End Date: Ongoing.
Background and Rationale: Depression and anxiety are common mental health conditions globally, significantly impacting individuals' quality of life. Cognitive Behavioral Therapy (CBT) is widely recognized for its effectiveness in modifying dysfunctional thinking and behaviors associated with psychological disorders. Ericksonian Hypnotherapy, utilizing hypnotic suggestion and accessing unconscious processes, offers a complementary approach. This study aims to evaluate and compare the therapeutic efficacy of these interventions in non-clinically diagnosed, yet symptomatic individuals.
Objective: To compare the effectiveness of Cognitive Behavioral Therapy and Ericksonian Hypnotherapy in reducing symptoms of depression and anxiety.
Study Design: This is a randomized, controlled, comparative trial involving three groups:
CBT group (15 participants) Ericksonian Hypnotherapy group (15 participants) Waiting list control group (15 participants)
Methods:
Participants: A total of 150 volunteers from Istanbul, aged 18-65, displaying symptoms of depression and anxiety without a clinical diagnosis. Screening will be conducted using socio-demographic forms, the Beck Depression Inventory (BDI), and the Beck Anxiety Inventory (BAI).
Intervention: Participants will be randomly assigned to receive either CBT or Ericksonian Hypnotherapy, with each intervention being administered over 12 sessions. Each session will be conducted in person and on a one-on-one basis, lasting approximately one hour, held once a week.
Control Group: Individuals in the control group will not receive any intervention during the study period but will be offered therapy sessions after the study's conclusion as compensation for their participation.
Measurements: Psychological assessments will be conducted at baseline and post-intervention using the BDI and BAI to measure changes in depression and anxiety symptoms.
Data Analysis: The effectiveness of the interventions will be analyzed using independent and paired t-tests to compare pre- and post-intervention scores within and between groups. ANOVA will be utilized for comparing the three groups, and effect sizes will be calculated to determine the clinical significance of the treatments.
Ethical Considerations: The study will adhere to the ethical standards of the Helsinki Declaration and has been approved by the Institutional Review Board of Istanbul Nişantaşı University numbered 2023/3. Informed consent will be obtained from all participants, ensuring confidentiality and the right to withdraw from the study at any time without any consequences.
Significance: By directly comparing two distinct therapeutic modalities, this study seeks to provide empirical evidence to inform clinical practices and potentially guide future psychological interventions aimed at treating depression and anxiety.
- Conditions
- Depression, Anxiety
- Being tested
- Cognitive Behavioral Therapy, Ericksonian Hypnotehrapy
- Keywords
- Cognitive Behavioral Therapy (CBT), Ericksonian Hypnotherapy, Depressive Disorder, Anxiety Disorders, Non-clinical Symptomatic Population
- Medical subject headings
- Depression, Anxiety Disorders, Depressive Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cognitive Behavioral TherapyBehavioural
Cognitive Behavioral Therapy (CBT) is a well-established psychological treatment that focuses on identifying, understanding, and changing negative thinking and behavior patterns. The intervention involves structured sessions where participants are taught strategies to alter detrimental thoughts and behaviors to improve emotional regulation and develop personal coping strategies that target solving current problems. In this study, CBT will be delivered in 12 one-hour weekly sessions conducted in person and on a one-on-one basis. This intervention is designed to reduce symptoms of depression and anxiety through cognitive restructuring and behavioral adaptations.
Ericksonian HypnotehrapyBehavioural
Ericksonian Hypnotherapy is a form of psychotherapy using clinical hypnosis and indirect suggestion to modify unconscious behaviors and thought patterns. Named after Dr. Milton H. Erickson, this therapeutic approach emphasizes adaptability and utilizes the patient's own experiences and internal resources for healing. The therapy is known for its effectiveness in addressing anxiety and depression by encouraging flexibility in perception and behavior. Like CBT, this intervention will be administered over 12 one-hour sessions, each conducted in person and tailored to the individual's unique psychological landscape.
| Study group | Role | What they receive |
|---|---|---|
| Cognitive Behavioral Therapy (CBT) Group | Experimental | Participants in this group will receive Cognitive Behavioral Therapy, which involves identifying and modifying negative thought patterns and behaviors to alleviate symptoms of depression and anxiety. Therapy sessions are conducted in person and on a one-on-one basis, ensuring tailored and direct therapeutic engagement. Each participant will attend 12 weekly sessions, each lasting approximately one hour. Receives: Behavioral: Cognitive Behavioral Therapy |
| Ericksonian Hypnotherapy Group | Experimental | This group will receive Ericksonian Hypnotherapy, a therapeutic approach that utilizes techniques of hypnosis and suggestion to access and alter subconscious processes, aiming to reduce psychological distress associated with depression and anxiety. Similar to the CBT group, sessions are delivered in person on a one-on-one basis, with a total of 12 weekly sessions, each one hour long. Receives: Behavioral: Ericksonian Hypnotehrapy |
| Control Group | No intervention | Participants in this group will not receive any active intervention during the study period. This group serves as a control to measure the natural progression of depression and anxiety symptoms without therapeutic intervention. Participants will be monitored throughout the study and will be offered therapeutic sessions after the study's conclusion as compensation for their participation. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Beck Depression Inventory (BDI) Scores
This outcome measures the change in depression levels among participants, as assessed by the Beck Depression Inventory. The BDI is a 21-item self-reported inventory that rates the severity of depression symptoms such as sadness, pessimism, sense of failure, and satisfaction in life, among others. The primary measure will be the difference in scores from baseline (pre-intervention) to post-intervention, indicating the efficacy of Cognitive Behavioral Therapy and Ericksonian Hypnotherapy in reducing depressive symptoms.
Measured: Baseline and 12 weeks post-intervention
Change in Beck Anxiety Inventory (BAI) Scores
This outcome measures the change in anxiety levels, assessed using the Beck Anxiety Inventory. The BAI is a 21-item self-reported scale that evaluates the severity of anxiety symptoms, including nervousness, fear, and physiological responses related to anxiety. The main focus will be on the difference in scores from baseline to after the completion of the interventions, showcasing the impact of the therapeutic approaches on anxiety reduction.
Measured: Baseline and 12 weeks post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jul 2024
- Study start4 Sep 2024
- Primary completion1 Dec 2025
- Study completion1 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Depression, AnxietyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Model Description: This study employs a randomized, controlled, parallel-group design to compare the effectiveness of Cognitive Behavioral Therapy (CBT) and Ericksonian Hypnotherapy in treating symptoms of depression and anxiety. The study includes three arms: CBT Group: Participants in this group will receive Cognitive Behavioral Therapy aimed at modifying negative thought patterns and behaviors to alleviate symptoms of depression and anxiety. Ericksonian Hypnotherapy Group: This group will undergo Ericksonian Hypnotherapy, which uses hypnosis and indirect suggestion to influence subconscious processes and mitigate psychological distress. Control Group: Participants in this group will not receive any intervention during the study period but will be monitored and offered therapy sessions after the study concludes, serving as a comparator to evaluate the efficacy of the interventions.
- Masking
- None (open label)
- Enrolment
- 45 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul Nisantasi University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Metin Çınaroğlu, Istanbul Nisantasi University
- Investigators
- Cemre Odabaşı, MA, Principal investigator, Clinical Psychology MA StudentFadime Çınar, phd, Principal investigator, Associate Professor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06484400
- Sponsor's protocol ID
- Nisantasi University
- Status last verified
- Jun 2026
- First submitted
- 26 Jun 2024
- Last updated
- 18 Jun 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Description: The research team intends to make de-identified individual participant data (IPD) and supplementary materials available to further scientific investigation, ensure transparency, and encourage data reuse. Data and Supplementary Materials to be Shared: The shared dataset will include de-identified demographic data, baseline and post-intervention outcomes measured by the Beck Depression Inventory and the Beck Anxiety Inventory, session attendance records, and any additional assessments performed as part of the study. Supplementary materials such as session protocols, statistical analysis scripts, and intervention manuals will also be made available.
Study at a glance
From the registry record, last updated by the sponsor on 18 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; Controlled Randomized Study
- ClinicalTrials.gov ID
- NCT06484400
- Acronym / sponsor ID
- Nisantasi University
- Conditions
- Depression, Anxiety
- Keywords
- Cognitive Behavioral Therapy (CBT), Ericksonian Hypnotherapy, Depressive Disorder, Anxiety Disorders, Non-clinical Symptomatic Population
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 45 participants (actual)
- Lead sponsor
- Istanbul Nisantasi UniversityUniversity, hospital or other
- Study start
- 4 Sep 2024 (actual)
- Primary completion
- 1 Dec 2025 (actual)
- Study completion
- 1 Dec 2025 (actual)
- First posted
- 3 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Title: Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; A Controlled Randomized Study.
Principal Investigator: Dr. Metin Çınaroğlu, Istanbul Nişantaşı University, Department of Psychology.
Study Duration: October, 2023 - Ongoing.
Objective: The study aims to compare the effectiveness of Cognitive Behavioral Therapy (CBT) and Ericksonian Hypnotherapy in alleviating symptoms of depression and anxiety among volunteers in Istanbul.
Methods: This randomized controlled trial will enroll healthy individuals aged 18-65 who exhibit symptoms of depression and anxiety but are not clinically diagnosed. Participants will be randomly divided into three groups: one receiving CBT, another receiving Ericksonian Hypnotherapy, and a control group receiving no therapeutic intervention. Standard psychological assessment tools such as the Beck Depression Inventory and Beck Anxiety Inventory will be used to measure outcomes.
Significance: Depression and anxiety are prevalent psychological disorders that significantly impair quality of life. Comparing these two therapeutic approaches may provide valuable insights into more effective psychological treatment strategies, thereby enhancing patient care in mental health settings.
Study Protocol:
Recruitment: 150 volunteers will be screened using socio-demographic forms and psychological assessments.
Intervention: Participants will undergo CBT or Ericksonian Hypnotherapy according to their group allocation, while the control group will be observed without intervention.
Evaluation: Pre- and post-treatment assessments will gauge the therapy's impact on depression and anxiety symptoms.
Expected Outcome: The study expects to demonstrate the relative efficacy of CBT and Ericksonian Hypnotherapy, providing evidence to guide treatment choices for managing depression and anxiety symptoms.
Detailed description
Study Title: Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; A Controlled Randomized Study.
Principal Investigator: Dr. Metin Çınaroğlu, Associate Professor, Department of Psychology, Istanbul Nişantaşı University.
Co-Investigators:
Expert Psychologist Dr. Eda Yılmazer, Department of Psychology, Beykoz University.
Psychologist Cemre Odabaşı, Clinical Psychology (Thesis) Student, Istanbul Nişantaşı University.
Dr. Selami Varol Ülker, Department of Psychology, Üsküdar University. Prof. Dr. Gökben Hızlı Sayar, Psychiatrist, Department of Psychiatry, Üsküdar University.
Study Duration: Start Date: October, 2023 - End Date: Ongoing.
Background and Rationale: Depression and anxiety are common mental health conditions globally, significantly impacting individuals' quality of life. Cognitive Behavioral Therapy (CBT) is widely recognized for its effectiveness in modifying dysfunctional thinking and behaviors associated with psychological disorders. Ericksonian Hypnotherapy, utilizing hypnotic suggestion and accessing unconscious processes, offers a complementary approach. This study aims to evaluate and compare the therapeutic efficacy of these interventions in non-clinically diagnosed, yet symptomatic individuals.
Objective: To compare the effectiveness of Cognitive Behavioral Therapy and Ericksonian Hypnotherapy in reducing symptoms of depression and anxiety.
Study Design: This is a randomized, controlled, comparative trial involving three groups:
CBT group (15 participants) Ericksonian Hypnotherapy group (15 participants) Waiting list control group (15 participants)
Methods:
Participants: A total of 150 volunteers from Istanbul, aged 18-65, displaying symptoms of depression and anxiety without a clinical diagnosis. Screening will be conducted using socio-demographic forms, the Beck Depression Inventory (BDI), and the Beck Anxiety Inventory (BAI).
Intervention: Participants will be randomly assigned to receive either CBT or Ericksonian Hypnotherapy, with each intervention being administered over 12 sessions. Each session will be conducted in person and on a one-on-one basis, lasting approximately one hour, held once a week.
Control Group: Individuals in the control group will not receive any intervention during the study period but will be offered therapy sessions after the study's conclusion as compensation for their participation.
Measurements: Psychological assessments will be conducted at baseline and post-intervention using the BDI and BAI to measure changes in depression and anxiety symptoms.
Data Analysis: The effectiveness of the interventions will be analyzed using independent and paired t-tests to compare pre- and post-intervention scores within and between groups. ANOVA will be utilized for comparing the three groups, and effect sizes will be calculated to determine the clinical significance of the treatments.
Ethical Considerations: The study will adhere to the ethical standards of the Helsinki Declaration and has been approved by the Institutional Review Board of Istanbul Nişantaşı University numbered 2023/3. Informed consent will be obtained from all participants, ensuring confidentiality and the right to withdraw from the study at any time without any consequences.
Significance: By directly comparing two distinct therapeutic modalities, this study seeks to provide empirical evidence to inform clinical practices and potentially guide future psychological interventions aimed at treating depression and anxiety.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
- Model description
- Model Description: This study employs a randomized, controlled, parallel-group design to compare the effectiveness of Cognitive Behavioral Therapy (CBT) and Ericksonian Hypnotherapy in treating symptoms of depression and anxiety. The study includes three arms: CBT Group: Participants in this group will receive Cognitive Behavioral Therapy aimed at modifying negative thought patterns and behaviors to alleviate symptoms of depression and anxiety. Ericksonian Hypnotherapy Group: This group will undergo Ericksonian Hypnotherapy, which uses hypnosis and indirect suggestion to influence subconscious processes and mitigate psychological distress. Control Group: Participants in this group will not receive any intervention during the study period but will be monitored and offered therapy sessions after the study concludes, serving as a comparator to evaluate the efficacy of the interventions.
| Arm | Type | Receives |
|---|---|---|
| Cognitive Behavioral Therapy (CBT) Group | Experimental | Behavioral: Cognitive Behavioral TherapyParticipants in this group will receive Cognitive Behavioral Therapy, which involves identifying and modifying negative thought patterns and behaviors to alleviate symptoms of depression and anxiety. Therapy sessions are conducted in person and on a one-on-one basis, ensuring tailored and direct therapeutic engagement. Each participant will attend 12 weekly sessions, each lasting approximately one hour. |
| Ericksonian Hypnotherapy Group | Experimental | Behavioral: Ericksonian HypnotehrapyThis group will receive Ericksonian Hypnotherapy, a therapeutic approach that utilizes techniques of hypnosis and suggestion to access and alter subconscious processes, aiming to reduce psychological distress associated with depression and anxiety. Similar to the CBT group, sessions are delivered in person on a one-on-one basis, with a total of 12 weekly sessions, each one hour long. |
| Control Group | No intervention | –Participants in this group will not receive any active intervention during the study period. This group serves as a control to measure the natural progression of depression and anxiety symptoms without therapeutic intervention. Participants will be monitored throughout the study and will be offered therapeutic sessions after the study's conclusion as compensation for their participation. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Age: Participants must be between 18 and 65 years old.
- Symptoms: Participants must display symptoms of depression and/or anxiety, but not necessarily have a clinical diagnosis.
- Voluntary Participation: Participants must voluntarily agree to participate and must be able to provide informed consent.
- Residency: Participants must reside in or near the study location (Istanbul) to attend in-person sessions.
- Language: Participants must be proficient in the language in which the therapy is delivered (presumably Turkish).
Key exclusion criteria (7 listed)
- Psychiatric Diagnosis: Individuals with a severe psychiatric disorder requiring immediate or intensive intervention (e.g., schizophrenia, bipolar disorder, or severe depression with suicidal ideation).
- Current Psychotherapy: Individuals currently receiving other forms of psychotherapy or psychological treatment.
- Substance Abuse: Individuals with active substance abuse issues or dependencies that could interfere with therapy.
- Cognitive Impairments: Individuals with cognitive impairments or neurological disorders that would limit their ability to participate fully in therapy.
- Medical Conditions: Individuals with severe medical conditions that could interfere with participation in the study or pose a risk during the therapy sessions.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cognitive Behavioral TherapyCognitive Behavioral Therapy (CBT) is a well-established psychological treatment that focuses on identifying, understanding, and changing negative thinking and behavior patterns. The intervention involves structured sessions where participants are taught strategies to alter detrimental thoughts and behaviors to improve emotional regulation and develop personal coping strategies that target solving current problems. In this study, CBT will be delivered in 12 one-hour weekly sessions conducted in person and on a one-on-one basis. This intervention is designed to reduce symptoms of depression and anxiety through cognitive restructuring and behavioral adaptations. | Behavioural | Cognitive Behavioral Therapy (CBT) Group |
| Ericksonian HypnotehrapyEricksonian Hypnotherapy is a form of psychotherapy using clinical hypnosis and indirect suggestion to modify unconscious behaviors and thought patterns. Named after Dr. Milton H. Erickson, this therapeutic approach emphasizes adaptability and utilizes the patient's own experiences and internal resources for healing. The therapy is known for its effectiveness in addressing anxiety and depression by encouraging flexibility in perception and behavior. Like CBT, this intervention will be administered over 12 one-hour sessions, each conducted in person and tailored to the individual's unique psychological landscape. | Behavioural | Ericksonian Hypnotherapy Group |
Primary outcome
Change in Beck Depression Inventory (BDI) Scores
Time frame: Baseline and 12 weeks post-intervention
This outcome measures the change in depression levels among participants, as assessed by the Beck Depression Inventory. The BDI is a 21-item self-reported inventory that rates the severity of depression symptoms such as sadness, pessimism, sense of failure, and satisfaction in life, among others. The primary measure will be the difference in scores from baseline (pre-intervention) to post-intervention, indicating the efficacy of Cognitive Behavioral Therapy and Ericksonian Hypnotherapy in reducing depressive symptoms.
Change in Beck Anxiety Inventory (BAI) Scores
Time frame: Baseline and 12 weeks post-intervention
This outcome measures the change in anxiety levels, assessed using the Beck Anxiety Inventory. The BAI is a 21-item self-reported scale that evaluates the severity of anxiety symptoms, including nervousness, fear, and physiological responses related to anxiety. The main focus will be on the difference in scores from baseline to after the completion of the interventions, showcasing the impact of the therapeutic approaches on anxiety reduction.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jun 2026.
- Individual participant dataSharing planned: Yes. Description: The research team intends to make de-identified individual participant data (IPD) and supplementary materials available to further scientific investigation, ensure transparency, and encourage data reuse. Data and Supplementary Materials to be Shared: The shared dataset will include de-identified demographic data, baseline and post-intervention outcomes measured by the Beck Depression Inventory and the Beck Anxiety Inventory, session attendance records, and any additional assessments performed as part of the study. Supplementary materials such as session protocols, statistical analysis scripts, and intervention manuals will also be made available.
Related trials for Depression, Anxiety
Not yet recruiting
Mandala Coloring in Late Pregnancy
Pregnancy, Anxiety
Not yet recruitingObservational study
Ecological Momentary Assessment of State-Dependent Decision-Making and Metacognition Across a Psychopathology Continuum
Depression, Anxiety
Not yet recruiting
Adapting the ESTEEM Intervention to Improve Mental Health and PrEP Uptake Among Men at Risk of HIV
PrEP Use
Active, not recruiting
Improving Student Mental Health Through a Universal Trauma-Informed Intervention
Anxiety Symptoms, Post-traumatic Stress Symptoms
Not yet recruiting
Health-Related Social Needs Food Boxes Delivery Program
Food Insecurity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Cemre Odabaşı, MA principal investigator
Clinical Psychology MA Student
Fadime Çınar, phd principal investigator
Associate Professor
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cognitive Behavioral Therapy and Ericksonian Hypnotehrapy in people with Depression, Anxiety, run by Istanbul Nisantasi University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Beck Depression Inventory (BDI) Scores (time frame: Baseline and 12 weeks post-intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2026.